As of 2026-10-10, the Relative Valuation of HLS Therapeutics Inc (HLS.TO) is (7.35) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.09 CAD, the upside of HLS Therapeutics Inc based on Relative Valuation is -279.8%.
The range of the Relative Valuation is (5.41) - (7.24) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 24.9x | 21.8x |
| Forward P/E multiples | 10.9x - 18.5x | 15.8x |
| Fair Price | (5.41) - (7.24) | (7.35) |
| Upside | -232.2% - -277.1% | -279.8% |
| Date | P/E |
| 2026-10-07 | -15.51 |
| 2026-10-06 | -15.32 |
| 2026-10-05 | -15.36 |
| 2026-10-02 | -14.12 |
| 2026-10-01 | -14.19 |
| 2026-09-30 | -15.32 |
| 2026-09-29 | -14.56 |
| 2026-09-28 | -14.60 |
| 2026-09-25 | -14.67 |
| 2026-09-24 | -14.38 |
| 2026-09-23 | -14.41 |
| 2026-09-22 | -14.45 |
| 2026-09-21 | -14.49 |
| 2026-09-18 | -14.27 |
| 2026-09-17 | -14.56 |
| 2026-09-16 | -14.70 |
| 2026-09-15 | -14.92 |
| 2026-09-14 | -15.14 |
| 2026-09-11 | -14.23 |
| 2026-09-10 | -13.61 |
| 2026-09-09 | -13.68 |
| 2026-09-08 | -13.79 |
| 2026-09-04 | -13.50 |
| 2026-09-03 | -13.14 |
| 2026-09-02 | -13.17 |
| 2026-09-01 | -13.68 |
| 2026-08-31 | -13.68 |
| 2026-08-28 | -13.83 |
| 2026-08-27 | -13.50 |
| 2026-08-26 | -13.32 |
| 2026-08-25 | -14.01 |
| 2026-08-24 | -13.46 |
| 2026-08-21 | -13.68 |
| 2026-08-20 | -14.38 |
| 2026-08-19 | -14.12 |
| 2026-08-18 | -14.23 |
| 2026-08-17 | -14.23 |
| 2026-08-14 | -14.23 |
| 2026-08-13 | -14.12 |
| 2026-08-12 | -14.52 |
| 2026-08-11 | -13.97 |
| 2026-08-10 | -14.30 |
| 2026-08-07 | -14.70 |
| 2026-08-06 | -14.60 |
| 2026-08-05 | -15.03 |
| 2026-08-04 | -15.03 |
| 2026-07-31 | -15.32 |
| 2026-07-30 | -15.32 |
| 2026-07-29 | -15.51 |
| 2026-07-28 | -15.36 |